Report on isoelectric focusing trial of erythropoietin profiling in two cancer patients during chemotherapy and darbepoetin treatment

Acta Chimica Slovenica

Volumn 58, Issue 1, 2011, Pages 139-143

  Španinger, Klemen ^a   Borštnar, Simona ^b   Matos, Erika ^b   Možina, Barbara ^b   Sytkowski, Arthur J ^c   Komel, Radovan ^a   Debeljak, Nataša ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Cisplatin chemotherapy; Darbepoetin alpha; Detection; Erythropoietin; Isoelectric focusing

Indexed keywords

EID: 79952904959     PISSN: 13180207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. W. Fried, Exp Hematol 2009, 37, 1007-15.
2. I. Wauters, J. Vansteenkiste, Expert Opin Biol Ther Expert Opin Biol Ther 2009, 9, 221-30.
3. A. J. Sytkowski, Sci STKE 2007, 2007, pe38.
4. N. Debeljak, A. J. Sytkowski. EpoR. UCSD-Nature Molecule Pages 2007: A000863.
5. J. W. Adamson, Am J Med 1996, 101, 4S-6S.
6. J. A. Pascual, V. Belalcazar, C. de Bolos, R. Gutierrez, E. Llop, J. Segura, Ther Drug Monit 2004, 26, 175-9.
7. M. Nangaku, R. Inagi, T. Miyata, T. Fujita, Nephron Exp Nephrol 2008, 110, e1-7.
8. M. R. K. C. Nowrousian, C. Oberhoff, U. Essers, R. Voigtmann, W. Gallasch, O. Quarder, in: M. Dekker (Ed.): Pathophysiology of cancer-related anemia, New York Basel Hong Kong, 1996.
9. P. A. Wood, W. J. M. Hrushesky, J Clin Inv 1995, 95, 1650-9.
10. P. H. Lai, R. Everett, F. F. Wang, T. Arakawa, E. Goldwasser, J Biol Chem 1986, 261, 3116-21.
11. F. Lasne, J. de Ceaurriz, Nature 2000, 405, 635.
12. S. Elliott, J. Egrie, J. Browne, T. Lorenzini, L. Busse, N. Rogers, I. Ponting, Exp Hematol 2004, 32, 1146-55.
13. F. Lasne, L. Martin, J. A. Martin, J. de Ceaurriz, Int J Biol Macromol 2007, 41, 354-7.
14. J. Zhang, U. Chakraborty, A. P. Villalobos, J. M. Brown, J. P. Foley, J Pharmaceut Biomed 2009, 50, 538-43.
15. W. Schlags, B. Lachmann, M. Walther, M. Kratzel, C. R. Noe, Proteomics 2002, 2, 679-82.
16. M. Lonnberg, M. Drevin, J. Carlsson, J Immunol Methods 2008, 339, 236-44.
17. O. P. Rabin, F. Lasne, J. A. Pascual, M. Saugy, F. J. Delbeke, P. Van Eenoo, Clinica Chimica Acta 2006, 373, 186-7; author reply 88.
18. J. G. Wright, A. V. Boddy, M. Highley, J. Fenwick, A. McGill, A. H. Calvert, Brit J Cancer 2001, 84, 452-9.
19. A. J. Sytkowski, J. W. Fisher, J Biol Chem 1985, 260, 14727-31.
20. F. Lasne, J Imminol Methods 2001, 235, 125-31
21. F. Lasne, L. Martin, N. Crepin, J. de Ceaurriz, Anal Biochem 2002, 311, 119-26
22. M. Lonnberg, M. Andren, G. Birgegard, M. Garle, J. Carlsson, Epo Isoform Determination in: H.P. Bruch, W. Kuhnel, Th. Martinetz, P. Schmucker (Eds.) Focus Uni Luebeck - 8th international Luebeck conference »Pathophysiology and Pharmacology of Erythropoietin and other Hemopoietic Growth Factros«, Luebeck, Germany, 2009, 39
23. M. O. Arcasoy, K. Amin, A. F. Karayal, S. C. Chou, J. A. Raleigh, M. A. Varia, Z. A. Haroon, Lab Invest 2002, 82, 911-8.
24. G. Acs, P. J. Zhang, T. R. Rebbeck, P. Acs, A. Verma, Cancer 2002, 95, 969-81
25. C. Bauer, M. L. Melamed, T. H. Hostetter, J Am Soc Nephrol 2008, 19, 844-6.
26. S. Lamon, L. Martin, N. Robinson, M. Saugy, J. Ceaurriz, F. Lasne, Clin J Sport Med 2009, 19, 311-5.